Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Blood|October 10, 2015
Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cellsPrashant Hiwarkar, Waseem Qasim, Ida Ricciardelli, et al.
British Journal of Haematology|November 18, 2003
Long-term follow-up of relapsed childhood acute lymphoblastic leukaemiaJudith M Chessells, Paul Veys, Helena Kempski, et al.
Journal of Hepatology|November 14, 2007
Evolution in the management of acute liver failure-associated aplastic anaemia in children: a single centre experienceNedim Hadzić, Susan Height, Sarah Ball, et al.
Clinical and Experimental Immunology|January 12, 2022
Diagnosis of HLH: two siblings, two distinct genetic causesClaire Escaron, Elizabeth Ralph, Shahnaz Bibi, et al.
British Journal of Clinical Pharmacology|February 21, 2020
Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioningBelén P Solans, Robert Chiesa, Bilyana Doncheva, et al.
Blood Advances|January 4, 2018
Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4<sup>+</sup> T-cell reconstitutionPrashant Hiwarkar, Mike Hubank, Waseem Qasim, et al.
Cells|January 17, 2019
Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell TransplantationGiorgio Ottaviano, Robert Chiesa, Tobias Feuchtinger, et al.
Pediatric Transplantation|July 1, 2014
A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiencyChristopher C Dvorak, Biljana N Horn, Jennifer M Puck, et al.
British Journal of Haematology|October 10, 2013
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantationFiona L Dignan, Robert F Wynn, Nedim Hadzic, et al.
British Journal of Haematology|September 14, 2011
Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantationAusten Worth, Rachel Conyers, Jonathon Cohen, et al.
Pageof 16